Adline Chem Lab Annual General Meeting
Adline Chem Lab Limited has scheduled its 38th Annual General Meeting for September 28, 2026. The meeting will be held via video conferencing.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
14 announcements with these filters
Adline Chem Lab Limited has scheduled its 38th Annual General Meeting for September 28, 2026. The meeting will be held via video conferencing.
Adline Chem Lab Ltd announced the resignation of its statutory auditor, Jain Kedia & Sharma. The Board appointed V. V. Patel & Co. to fill the vacancy.
Adline Chem Lab Ltd announced its AGM date of September 28, 2026, and the appointment of Mrs. Anita Ganeshbhai Marvadi as an Independent Director.
Adline Chem Lab Ltd scheduled a Board Meeting for August 27, 2026, to discuss the upcoming AGM, annual reports, and director appointments.
Adline Chem Lab Ltd reported net profit of ₹0 Cr for Q1 FY27.
Adline Chem Lab Limited has scheduled a board meeting for August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ended June 30, 2026.
Adline Chem Lab Ltd filed its quarterly shareholding pattern. The report provides a detailed breakdown of promoter and public equity holdings.
Two independent directors resigned from Adline Chem Lab Ltd due to personal commitments. The departures require the company to find replacements to maintain board composition.
Adline Chem Lab Ltd reported a net loss of ₹0.1 Cr for Q4 FY26.
Adline Chem Lab Limited approved audited standalone financial results for the fiscal year ended March 31, 2026. The board meeting concluded with an unmodified audit opinion.
Adline Chem Lab scheduled a board meeting for May 29, 2026, to approve audited FY26 financial results. Trading window remains closed until June 1, 2026.
Adline Chem Lab Ltd confirmed it does not meet the 'Large Corporate' criteria for the financial year ended March 31, 2026. Consequently, the company has no mandatory requirement to raise funds through debt securities. The filing reports nil incremental borrowings and zero shortfall in debt-sourcing obligations for the two-year block period.
Adline Chem Lab Limited confirmed it does not meet the criteria for a 'Large Corporate' under SEBI norms for FY 2025-26. The company reported outstanding borrowings of ₹1.73 Crore as of March 31, 2026, exempting it from specific debt-raising requirements.
Adline Chem Lab Limited informed BSE that the Annual Secretarial Compliance Report for FY 2025-26 is not applicable. The company qualifies for exemption under SEBI LODR Regulation 15(2) as its paid-up equity capital (₹5.85 Crore) and net worth remain below the mandatory thresholds of ₹10 Crore and ₹25 Crore respectively.